TICKERNOMICS Sign up
Last Update: 2024-03-28 02:15:44
CohBar Inc. ( CWBR ) https://www.cohbar.com
0.76USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-53.06%
CWBR
SPY
32.74%
-44.09%
CWBR
SPY
92.93%
-76.67%
CWBR
SPY
224.41%
CWBR
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2.21
-3.91
0.00
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.18
0.00
0.23
-318.38
0.00
0.25
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
-26.5398
-407.38
-142.80
-8.26
Other Earnings and Cash Flow Stats:
CohBar Inc. ( CWBR ) Net Income TTM ($MM) is -13.02
CohBar Inc. ( CWBR ) Operating Income TTM ($MM) is -13.57
CohBar Inc. ( CWBR ) Owners' Earnings Annual ($MM) is 0.00
CohBar Inc. ( CWBR ) Current Price to Owners' Earnings ratio is 0.00
CohBar Inc. ( CWBR ) EBITDA TTM ($MM) is -13.22
CohBar Inc. ( CWBR ) EBITDA Margin is 0.00%
Capital Allocation:
CohBar Inc. ( CWBR ) has paid 0.00 dividends per share and bought back -0.0067239999999997 million shares in the past 12 months
CohBar Inc. ( CWBR ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
CohBar Inc. ( CWBR ) Interest-bearing Debt ($MM) as of last quarter is 0
CohBar Inc. ( CWBR ) Annual Working Capital Investments ($MM) are -2
CohBar Inc. ( CWBR ) Book Value ($MM) as of last quarter is 9
CohBar Inc. ( CWBR ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
CohBar Inc. ( CWBR ) has 6 million in cash on hand as of last quarter
CohBar Inc. ( CWBR ) has 3 million of liabilities due within 12 months, and long term debt 0 as of last quarter
CohBar Inc. ( CWBR ) has 2 common shares outstanding as of last quarter
CohBar Inc. ( CWBR ) has 0 million USD of preferred stock value
Academic Scores:
CohBar Inc. ( CWBR ) Altman Z-Score is -14.34 as of last quarter
CohBar Inc. ( CWBR ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
CohBar Inc. ( CWBR ) largest shareholder is Royal Bank of Canada owning 90 shares at 0.00 ($MM) value
Biunno Jeffrey Francis(CFO, Treasurer and Secretary) Bought 75000 shares of CohBar Inc. ( CWBR ) for the amount of $0.00 on 2021-12-29
15.09% of CohBar Inc. ( CWBR ) is held by insiders, and 9.28% is held by institutions
CohBar Inc. ( CWBR ) went public on 2015-01-28
Other CohBar Inc. ( CWBR ) financial metrics:
FCF:-9.73
Unlevered Free Cash Flow:-14.19
EPS:-5.96
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-182.33
Beta:-8.26
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About CohBar Inc. ( CWBR ) :
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.